Alterity Therapeutics Limited
ATH
Kedudukan dalam Saham
#25472
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Harga Saham
$0.21511186
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$47.00M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-38.54%
Negara
AU
Perdagangan Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Modal pasaran bagi Alterity Therapeutics Limited(ATH)
Modal Pasaran: $47.00M
Sehingga October 2026, Alterity Therapeutics Limited mempunyai modal pasaran sebanyak $47.00M. Ini menjadikan Alterity Therapeutics Limited syarikat ke-25472nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Alterity Therapeutics Limited dari 2012 hingga 2026
ATH berbanding dengan 5 teratas yang paling popular stocks
